Thijs Spoor is the founder of Perspective Therapeutics. Latest round: Series B. Based in San Diego, California.
Thijs Spoor is the Chief Executive Officer of Perspective Therapeutics, a clinical-stage radiopharmaceutical company pioneering targeted alpha treatments for cancers including neuroendocrine tumors and melanoma. He leads the company's integrated approach spanning molecule discovery, clinical development, and commercialization, emphasizing a platform that uses 'elemental twins' to image patients before inducing radiation. Spoor has discussed Perspective's recent $175M financing and the company's path toward registration-enabling studies for its lead program VMT-α-NET.
Full founder directory · Investor directory · Company funding database · Fundraising library